Allergan announced on July 24, 2019 that it was launching a voluntary, global withdrawal of its Biocell textured breast implants and tissue expanders. The withdrawal follows increased scrutiny of textured breast implants and their connection to BIA-ALCL – a rare lymphoma which can develop around breast implants. The FDA has said that women who have Allergan textured implants and are symptom free do not need to undergo explantation (removal) . If a woman with Allergan textured implants wished to have them removed and replaced with smooth Implants Allergan will provide at no charge smooth Allergan implants.